Compare LAW & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LAW | PACB |
|---|---|---|
| Founded | 2013 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 466.2M | 459.0M |
| IPO Year | 2021 | 2010 |
| Metric | LAW | PACB |
|---|---|---|
| Price | $4.48 | $1.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 5 |
| Target Price | ★ $8.00 | $2.10 |
| AVG Volume (30 Days) | 607.9K | ★ 5.8M |
| Earning Date | 05-25-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.58 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $156,849,000.00 | $93,468,000.00 |
| Revenue This Year | $11.23 | $11.22 |
| Revenue Next Year | $10.60 | $12.41 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 8.29 | 3.04 |
| 52 Week Low | $2.45 | $0.85 |
| 52 Week High | $9.11 | $2.73 |
| Indicator | LAW | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 52.00 | 34.01 |
| Support Level | $3.92 | $1.18 |
| Resistance Level | $4.81 | $1.37 |
| Average True Range (ATR) | 0.39 | 0.10 |
| MACD | 0.22 | -0.01 |
| Stochastic Oscillator | 81.13 | 14.55 |
CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.